SEER INC. - CLASS A COMMON STOCK

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

21 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Seer to Participate in Upcoming November Investor Conferences

08 ноя 2024 07:00:08 Источник Nasdaq GlobeNewswire

Seer Reports Third Quarter 2024 Financial Results

06 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

06 ноя 2024 16:03:00 Источник Nasdaq GlobeNewswire

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

31 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

21 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

17 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

22 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

Seer Appoints Nicolas Roelofs to its Board of Directors

14 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference

09 авг 2024 07:00:53 Источник Nasdaq GlobeNewswire

Seer Reports Second Quarter 2024 Financial Results

08 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

Seer to Report Second Quarter 2024 Financial Results on August 8, 2024

18 июл 2024 16:03:00 Источник Nasdaq GlobeNewswire

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery

11 июн 2024 11:11:56 Источник Nasdaq GlobeNewswire

Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study

02 июн 2024 10:55:00 Источник Nasdaq GlobeNewswire

Seer Reports First Quarter 2024 Financial Results

08 май 2024 16:05:47 Источник Nasdaq GlobeNewswire

Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions

08 май 2024 16:03:00 Источник Nasdaq GlobeNewswire

Seer to Report First Quarter 2024 Financial Results on May 8, 2024

23 апр 2024 16:05:00 Источник Nasdaq GlobeNewswire

Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook

29 фев 2024 16:05:12 Источник Nasdaq GlobeNewswire

Seer to Participate in the TD Cowen 44th Annual Health Care Conference

21 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery

06 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire